Friday, October, 23, 2009

Drug Classification Of Humira

Health Encyclopedia: Psoriasis Highlights

Highlights

Research

A study released in October 2006 shows an increased risk of heart attacks in people with psoriasis. The risk was highest in young patients with severe psoriasis.

Drug Research

Results from a Phase III (late-stage) study show that adalimumab (Humira) is more effective than methotrexate in the treatment of moderate-to-severe psoriasis. In the study, 80% of patients treated for 16 weeks with adalimumab reported a 75% or better improvement, compared with 36% of patients treated with ...

View all »

Expert & Community Posts

Crohn's & Colitis Medications: A look at IBD Treatment Advances

By Elizabeth Roberts , Health Expert

...Biologics include Remicade (approved for CD and UC), Humira, (approved for CD), Tysabri... Read more »

Diagnosed with IBD. . . Now What? (Pt. 1)

By Elizabeth Roberts , Health Expert

...drugs being used to treat IBD and include Remicade®, Humira®, Cimzia®, and Tysabri®. These... Read more »

Besides Remicade, what other medications can be used for inflammatory bowel disease?

By Todd Eisner , Health Expert

...only Remicade is approved for Ulcerative Colitis. Humira, Cimzia and Tysabri have been used for... Read more »

Studies Assess Effectiveness of Orencia and Humira in Children with JRA

By Christine Miller , Health Expert

...annual meeting in Washington showed that Orencia and Humira, drugs approved for treating adults... Read more »

Go to Posts »

Health Guide

Rheumatoid Arthritis: Treatment

...factor (TNF). Current anti-TNF drugs include infliximab (Remicade), etanercept (Enbrel), and adalimumab (Humira). Other biologic response modifiers include the interleukin-1 antagonist anakinra... Read more »

Rheumatoid Arthritis: Highlights

...remission. Among these findings:A combination of methotrexate (Rheumatrex, Trexall) and adalimumab (Humira) works better in improving symptoms and achieving remission than either drug alone.A... Read more »

Crohn's Disease: Highlights

Drug ApprovalAdalimumab (Humira) was approved in 2007 to treat adults with moderate-to-severe Crohn's disease.Infliximab (Remicade) was approved in 2006 for treating active Crohns disease... Read more »

Scleroderma: Other Treatments

...scleroderma. The current agents include infliximab (Remicade), etanercept (Enbrel), and adalimumab (Humira).Halofuginone. Halofuginone, a drug that slows down the synthesis of collagen, is showing... Read more »

Psoriasis: Other Medications

...clinic. Patients with a history of infection or heart failure should not take this drug.Adalimumab (Humira) is another TNF-blocker. It is being tested in clinical trials for treatment of psoriasis... Read more »

Images

Vitiligo, drug induced

Related News

Humira launched for Crohn's disease in Europe

October 03, 2008

Drugmaker Abbott has launched Humira for the treatment of Crohn's disease in the United Kingdom. In April, the European Medicines Agency recommended... Read summary »

European agency recommends approval of Humira for Crohn's

October 02, 2008

A scientific committee has recommended that the European Medicines Agency approve Humira for the treatment of Crohn's disease. Experts say the... Read summary »

Humira approved for treating psoriatic arthritis joint damage

October 02, 2008

The Food and Drug Administration has approved Humira for a new use. Humira may now be used to slow joint damage in people with psoriatic arthritis.... Read summary »

Weight of the World

October 25, 2007

(Ivanhoe Newswire) -- The growing number of overweight or obese people isn't restricted to the United States; it's a problem worldwide. Data... Read summary »

Treating Obesity as an Addiction?

August 28, 2008

(Ivanhoe Newswire) -- Using a drug designed to fight drug addiction may be helpful in combating obesity. Vigabatrin, a drug designed as a potential... Read summary »

Go to News »

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyOsteoarthritisCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.